Drug-industry survey blames insurer practices for barriers to care June 6, 2022 Auto Bot BioPharma, biopharma nl, drug costs, drug pricing, health insurers, News, Pharma, PhRMA, Policy, Prior Authorization, Social Determinants 0 Pharma companies often take the blame for high prescription costs. But a new, industry-sponsored survey shifts attention to insurance industry practices.